About Terveystalo Tampere
"Tule turvallisesti paikan päälle tai asioi etänä. Varaa aika verkkosivuiltamme tai asiakaspalvelun kautta numerosta 030 6000. Ajanvaraus on auki vuorokauden ympäri. Koko Suomen kattavaa toimipaikkaverkostoa täydentävät ympäri vuorokauden saatavilla olevat digitaaliset etäpalvelut. Lääkäri-chat päivystää ilman ajanvarausta 24/7. Voit myös varata ajan video- tai puhelinvastaanotolle valitsemallesi asiantuntijalle. Nopeasti hyvään hoitoon!"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Pfizer
3
Bristol-Myers Squibb
2
H. Lundbeck A/S
2
Amgen
1
Bayer
1
Biohit Oyj
1
Chordate Medical
1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
1
European Huntington's Disease Network
1
Tampere University
1
Clinical Trials at Terveystalo Tampere
During the past decade, Terveystalo Tampere conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on
average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)
2004-06-01
2017-06-30
Completed
10,000
The Efficacy of L-cysteine in Prevention of Cluster Headache
2013-12-17
2020-10-14
Completed
60
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps
2017-11-21
2019-03-07
Completed
127
Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine
2018-03-22
2022-08-01
Completed
144
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
An Open-Label Crenezumab Study in Participants With Alzheimer's Disease
2018-04-11
2019-05-31
Terminated
149
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Terveystalo Tampere" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Pfizer" with 3 trials
sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Terveystalo Tampere"
#1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator, "Kuopio University Hospital" with 1 trials as a collaborator, "Oulu University Hospital" with 1 trials as a collaborator, "Tampere University Hospital" with 1 trials as a collaborator and "Terveystalo" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Terveystalo Tampere
According to Clinical.Site data, the most researched conditions in "Terveystalo Tampere" are
"Alzheimer's Disease" (2 trials), "Psoriasis" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atopic Dermatitis" (1 trials) and "Bronchiolitis; Obstruction" (1 trials). Many other conditions were trialed in "Terveystalo Tampere" in a lesser frequency.
Clinical Trials Intervention Types at Terveystalo Tampere
Most popular intervention types in "Terveystalo Tampere" are "Drug" (12 trials), "Device" (3 trials), "Biological" (2 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Abrocitinib 200 mg" (2 trials), "BMS-986165" (2 trials), "Crenezumab" (2 trials) and "Eptinezumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Terveystalo Tampere
The vast majority of trials in "Terveystalo Tampere" are
18 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Terveystalo Tampere
Currently, there are NaN active trials in "Terveystalo Tampere".
undefined are not yet recruiting,
2 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Terveystalo Tampere,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Terveystalo Tampere, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 4 trials that are defined as “Not Applicable".